Ischemic Heart Disease
IHD is caused by myocardial ischemia due to
Imbalance between the myocardial oxygen demand and supply from the coronary arteries.
Majority of cases due to
Reduction in coronary artery blood flow caused by
Obstructive atherosclerotic disease.
IHD is also known as Coronary artery disease
Echocardiography is the test of choice for evaluating pericardial effusions and cardiac tamponade. Characteristic findings include identifying the size and location of a pericardial effusion, end-diastolic chamber collapse, and respiratory variations in transvalvular flow velocities. Right atrial and ventricular collapse on expiration as well as dilatation of the IVC that fails to collapse with inspiration also suggest tamponade. Echocardiography allows for rapid assessment but findings may be absent in patients with pulmonary hypertension or RV hypertrophy.
Aortic regurgitation occurs when the aortic valve does not close properly, allowing blood to flow back into the left ventricle. It can be caused by conditions that damage the aortic valve such as rheumatic fever or a congenital heart defect. Symptoms may include breathlessness, fatigue, and chest pain. Diagnosis is made through echocardiogram which can assess the severity. Treatment depends on severity but may involve lifestyle changes, medications, or aortic valve replacement surgery if symptoms worsen or damage to the heart progresses. Prognosis depends on severity and treatment, with severe untreated cases having a high risk of heart failure or sudden cardiac death.
Infective Endocarditis(IE)
Is due to bacterial or fungal infection of the heart valves (endocardium).
Characterized by:
Formation of bulky, friable,easily detached and infected vegetations.
Damage to heart Valves and Chorda tendinae
perforation, ulceration, destruction (causes valve dysfunction)
The document discusses pathophysiology of mitral valve diseases. It begins with an overview of rheumatic fever and rheumatic heart disease as the leading cause of mitral stenosis worldwide. It then covers the anatomy of the mitral valve and describes the pathogenesis and hemodynamic consequences of mitral stenosis, including left atrial pressure overload, pulmonary hypertension, and symptoms like dyspnea. Late stages can involve left ventricular dysfunction. The document also briefly discusses etiology, classification and mechanisms of mitral regurgitation.
This document describes various congenital heart diseases (CHD) including their embryology, classification, pathophysiology and clinical presentations. It discusses abnormalities causing left-to-right shunts such as ventricular septal defects, atrial septal defects and patent ductus arteriosus which can cause volume overload. It also describes right-to-left shunting defects like tetralogy of Fallot and transposition of the great arteries which result in cyanosis. Obstructive lesions including coarctation of the aorta are also summarized. Fetal circulation is compared to changes at birth.
Cardiomyopathies are diseases of the heart muscle that result from various causes such as genetic defects, injury to heart muscle cells, or infiltration of heart tissue. There are several classifications of cardiomyopathies including dilated, hypertrophic, restrictive, and arrhythmogenic right ventricular cardiomyopathy. Dilated cardiomyopathy is the most common type and results in enlarged heart chambers and impaired contraction. Hypertrophic cardiomyopathy is characterized by abnormal thickening of the heart muscle and can lead to obstruction of blood flow. Restrictive cardiomyopathy involves scarring or infiltration of the heart muscle which restricts the filling of the heart chambers. The document provides details on the definitions, causes, clinical presentations, diagnostic evaluations, and management of these
Ischemic Heart Disease
IHD is caused by myocardial ischemia due to
Imbalance between the myocardial oxygen demand and supply from the coronary arteries.
Majority of cases due to
Reduction in coronary artery blood flow caused by
Obstructive atherosclerotic disease.
IHD is also known as Coronary artery disease
Echocardiography is the test of choice for evaluating pericardial effusions and cardiac tamponade. Characteristic findings include identifying the size and location of a pericardial effusion, end-diastolic chamber collapse, and respiratory variations in transvalvular flow velocities. Right atrial and ventricular collapse on expiration as well as dilatation of the IVC that fails to collapse with inspiration also suggest tamponade. Echocardiography allows for rapid assessment but findings may be absent in patients with pulmonary hypertension or RV hypertrophy.
Aortic regurgitation occurs when the aortic valve does not close properly, allowing blood to flow back into the left ventricle. It can be caused by conditions that damage the aortic valve such as rheumatic fever or a congenital heart defect. Symptoms may include breathlessness, fatigue, and chest pain. Diagnosis is made through echocardiogram which can assess the severity. Treatment depends on severity but may involve lifestyle changes, medications, or aortic valve replacement surgery if symptoms worsen or damage to the heart progresses. Prognosis depends on severity and treatment, with severe untreated cases having a high risk of heart failure or sudden cardiac death.
Infective Endocarditis(IE)
Is due to bacterial or fungal infection of the heart valves (endocardium).
Characterized by:
Formation of bulky, friable,easily detached and infected vegetations.
Damage to heart Valves and Chorda tendinae
perforation, ulceration, destruction (causes valve dysfunction)
The document discusses pathophysiology of mitral valve diseases. It begins with an overview of rheumatic fever and rheumatic heart disease as the leading cause of mitral stenosis worldwide. It then covers the anatomy of the mitral valve and describes the pathogenesis and hemodynamic consequences of mitral stenosis, including left atrial pressure overload, pulmonary hypertension, and symptoms like dyspnea. Late stages can involve left ventricular dysfunction. The document also briefly discusses etiology, classification and mechanisms of mitral regurgitation.
This document describes various congenital heart diseases (CHD) including their embryology, classification, pathophysiology and clinical presentations. It discusses abnormalities causing left-to-right shunts such as ventricular septal defects, atrial septal defects and patent ductus arteriosus which can cause volume overload. It also describes right-to-left shunting defects like tetralogy of Fallot and transposition of the great arteries which result in cyanosis. Obstructive lesions including coarctation of the aorta are also summarized. Fetal circulation is compared to changes at birth.
Cardiomyopathies are diseases of the heart muscle that result from various causes such as genetic defects, injury to heart muscle cells, or infiltration of heart tissue. There are several classifications of cardiomyopathies including dilated, hypertrophic, restrictive, and arrhythmogenic right ventricular cardiomyopathy. Dilated cardiomyopathy is the most common type and results in enlarged heart chambers and impaired contraction. Hypertrophic cardiomyopathy is characterized by abnormal thickening of the heart muscle and can lead to obstruction of blood flow. Restrictive cardiomyopathy involves scarring or infiltration of the heart muscle which restricts the filling of the heart chambers. The document provides details on the definitions, causes, clinical presentations, diagnostic evaluations, and management of these
Left ventricular non-compaction cardiomyopathy (LVNC) is a rare genetic heart condition characterized by a thickened myocardium with prominent trabeculations. It occurs when the myocardium fails to compact properly during fetal development. LVNC can be isolated or associated with other heart defects, and presents variably from being asymptomatic to causing heart failure, arrhythmias, blood clots, or sudden cardiac death. Diagnosis is made through echocardiogram, cardiac MRI, or CT scan finding an excessive trabeculated myocardium. Treatment focuses on managing complications like heart failure or arrhythmias. Prognosis depends on symptoms and ejection fraction, with mortality over 40% at 5 years in symptomatic patients.
The patient presented with symptoms of chest pain, shortness of breath, and sweating. ECG and blood tests showed elevated cardiac markers. This is consistent with a diagnosis of myocardial infarction (MI). MI occurs when blood flow to the heart is blocked, causing heart muscle cell death. On pathology, MI presents as areas of necrosis and inflammation. Laboratory tests for MI diagnosis include cardiac troponins, CK-MB, and myoglobin, which are more specific and sensitive than total CK or LDH. Together, the presentation and test results make the diagnosis of MI likely in this case.
The cardiac structure includes the heart walls and chambers. Cardiac hypertrophy is an increase in heart size and weight due to mechanical overload. It can be concentric from pressure overload or eccentric from volume overload. Heart failure occurs when the heart cannot pump adequately to meet metabolic demands. It can be due to systolic or diastolic dysfunction. Right heart failure causes venous congestion while left heart failure causes pulmonary congestion.
This document discusses constrictive pericarditis, which occurs when the pericardium thickens and restricts heart function. It can develop acutely from cardiac tamponade, or chronically from conditions like prior cardiac surgery, radiation therapy, or tuberculosis. Symptoms include fluid overload and reduced cardiac output with exertion. Evaluation involves ECG, echocardiogram, CT/MRI, and measuring ventricular filling pressures. Treatment depends on whether the constriction is transient, chronic, or occult. Chronic symptomatic cases require pericardiectomy, while transient cases may resolve with medications over time.
The document discusses the anatomy, functions, pathophysiology, etiologies, clinical features, diagnosis and treatment of pericardial diseases including pericarditis, pericardial effusion, cardiac tamponade, and constrictive pericarditis. Key points include: the pericardium has visceral and parietal layers separated by pericardial fluid; pericarditis can be caused by infection, autoimmune disorders, neoplasms or trauma; tamponade occurs when fluid rapidly accumulates under pressure, compressing the heart; constrictive pericarditis involves fibrosis and scarring that restricts diastolic filling.
The document summarizes mitral valve disorders including mitral stenosis and mitral regurgitation. It covers the anatomy of the mitral valve and describes valvular heart diseases such as stenosis and regurgitation. For mitral stenosis, it discusses etiology as being primarily rheumatic fever, pathophysiology involving decreased mitral valve area and increased left atrial pressure, clinical features such as dyspnea and pulmonary hypertension, physical exam findings including murmurs, and treatment including valve repair/replacement and rate control for atrial fibrillation. For mitral regurgitation, it similarly discusses etiology, pathophysiology, clinical features, exam, workup and treatment involving surgical repair or replacement.
- Constrictive pericarditis results from scarring and loss of elasticity of the pericardial sac, typically due to chronic inflammation and sometimes calcification. This causes the pericardium to thicken and lose its ability to expand and contract normally.
- The inelastic pericardium prevents normal filling of the heart chambers, especially in mid to late diastole. Inspiration does not decrease pressure in the left ventricle as it normally would due to the thickened pericardium isolating the heart.
- Diagnosis involves physical exam findings like elevated JVP, hepatomegaly, and Kussmaul's sign combined with echocardiography findings like sept
The document provides an overview of pericardial disease including pericarditis, pericardial effusion, cardiac tamponade, and constrictive pericarditis. It discusses the structure and function of the pericardium, signs and symptoms, causes, investigations, and treatments for each condition. Acute pericarditis is usually caused by viral infection and presents with chest pain relieved by sitting forward. Pericardial effusion can lead to cardiac tamponade seen by increased jugular venous pressure and pulsus paradoxus. Constrictive pericarditis is a chronic thickening and scarring of the pericardium most often caused by tuberculosis.
This document discusses the anatomy, assessment, and management of tricuspid valve disease. It covers tricuspid stenosis and tricuspid regurgitation. For tricuspid stenosis, the most common causes are rheumatic fever and infective endocarditis. Symptoms include fatigue and swelling. Transthoracic echocardiogram is used to assess the mean gradient and valve morphology. For tricuspid regurgitation, the most common primary causes are rheumatic fever and carcinoid heart disease. Secondary causes are related to right ventricular dilation. Symptoms are similar to stenosis. Echocardiogram can assess the severity of regurgitation and pulmonary pressures. Management involves medical therapy depending on severity of disease.
This document discusses hypertrophic cardiomyopathy (HCM), including its definition, causes, variants, pathophysiology, clinical presentation, diagnostic workup, and management. Key points include:
- HCM is defined by left and/or right ventricular hypertrophy, usually involving the septum with a thickness over 15mm. It is commonly caused by genetic mutations affecting cardiac proteins.
- Presentation can range from being asymptomatic to symptoms of heart failure, angina, or syncope. Exams may reveal murmurs and EKGs often show abnormal patterns. Echocardiograms and cardiac catheterization are used for diagnosis and assessment.
- Management involves medications like beta-blockers to reduce
Mitral stenosis is usually caused by rheumatic fever, which causes fusion and thickening of the mitral valve, restricting its opening. This restricts blood flow from the left atrium to the left ventricle, causing left atrial pressure to rise and lead to pulmonary congestion and breathlessness. The elevated left atrial pressure also raises pulmonary pressures over time, causing pulmonary hypertension, right heart strain, and eventual right heart failure if left untreated. Diagnosis is made through echocardiogram and symptoms include dyspnea, fatigue, chest pain, cough, and palpitations from potential atrial fibrillation. Treatment involves antibiotics to prevent future rheumatic fever, diuretics, and potentially mitral
This document discusses the echocardiographic evaluation of cardiomyopathies. It defines cardiomyopathy and outlines the major classification systems. The main types discussed are dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, restrictive cardiomyopathy, and unclassified cardiomyopathy. Specific features of dilated cardiomyopathy are then reviewed in detail, including morphological features, causes, Doppler findings, and involvement of the right ventricle and left atrium. Evaluation of diastolic dysfunction and ischemic cardiomyopathy are also summarized.
Atrial myxomas are the most common primary cardiac tumors. They typically arise from the interatrial septum and can cause obstruction of blood flow or embolic events. Clinical presentations include signs of congestive heart failure, systemic embolism, and constitutional symptoms. Echocardiography is the primary diagnostic tool and surgical resection is the only effective treatment. While most myxomas are sporadic, around 5% are familial with an inherited pattern and higher recurrence rates after surgery.
Normal Heart
Fist size muscular pump
Pumps 6000 lit of blood daily
Perfuses
tissues with nutrients and
Facilitates
removal of waste products.
Heart diseases
Have severe physiologic consequences
Are leading cause of morbidity and mortality in developed nations
750,000 deaths/ year (In US
Dr Vivek Baliga discusses left atrial myxoma for medical students. Lecture includes a link to MCQs in the video. For access to video, please copy and paste this link --> https://youtu.be/JtkWxbVklgA
This document discusses rheumatic valvular heart disease, focusing on mitral regurgitation, mitral stenosis, and aortic regurgitation.
It begins by outlining the learning objectives and providing an introduction on rheumatic heart disease and how it causes permanent valve damage. The pathophysiology, clinical manifestations, diagnostic modalities, and treatment options are then described for each of the three valvular lesions.
Prevention through secondary prophylaxis with antibiotic administration is emphasized, as 40-60% of patients with acute rheumatic fever can develop rheumatic heart disease without proper prevention. Education is highlighted as critical to ensure patient understanding and adherence to long-term prophylaxis.
Cardiomyopathy refers to diseases of the heart muscle that weaken the heart's ability to pump blood. Dilated cardiomyopathy is characterized by the enlargement and weakening of the heart's main pumping chamber, the left ventricle. The major causes of dilated cardiomyopathy include infections, toxins, inherited conditions, and unknown causes. Symptoms include heart failure and arrhythmias. Diagnosis involves echocardiography and treatments focus on managing symptoms through medications, devices, and transplantation if needed.
This document provides an overview of hypertrophic cardiomyopathy (HCM). It begins with definitions of cardiomyopathy and HCM. It then discusses the historical perspective, genetic basis, morphology, pathophysiology, clinical features, diagnosis, and management of HCM. Some key points include:
- HCM is a genetic heart condition characterized by unexplained thickening of the heart muscle. It is the most common cause of sudden cardiac death in young people.
- The genetic basis involves mutations in genes encoding sarcomere proteins. This leads to impaired relaxation and increased calcium sensitivity of the heart muscle.
- Morphologically, HCM involves asymmetric left ventricular hypertrophy and abnormalities of the mitral valve apparatus. Hist
Infective Endocarditis and It's Surgical ManagementAlireza Kashani
This document defines and describes infective endocarditis. Key points include:
- Infective endocarditis involves infection of the heart valves or structures, most commonly the valves. This can lead to valvular dysfunction, sepsis, or embolism.
- The infection involves bacterial, viral, or fungal invasion of the endocardium and formation of vegetations on the valves or endocardium.
- Risk factors include underlying heart conditions, IV drug use, dental procedures, and indwelling catheters. The aortic and mitral valves are most commonly involved.
- Symptoms may include fever, heart murmur, embolic phenomena, and heart failure. Diagnosis
Left ventricular non-compaction cardiomyopathy (LVNC) is a rare genetic heart condition characterized by a thickened myocardium with prominent trabeculations. It occurs when the myocardium fails to compact properly during fetal development. LVNC can be isolated or associated with other heart defects, and presents variably from being asymptomatic to causing heart failure, arrhythmias, blood clots, or sudden cardiac death. Diagnosis is made through echocardiogram, cardiac MRI, or CT scan finding an excessive trabeculated myocardium. Treatment focuses on managing complications like heart failure or arrhythmias. Prognosis depends on symptoms and ejection fraction, with mortality over 40% at 5 years in symptomatic patients.
The patient presented with symptoms of chest pain, shortness of breath, and sweating. ECG and blood tests showed elevated cardiac markers. This is consistent with a diagnosis of myocardial infarction (MI). MI occurs when blood flow to the heart is blocked, causing heart muscle cell death. On pathology, MI presents as areas of necrosis and inflammation. Laboratory tests for MI diagnosis include cardiac troponins, CK-MB, and myoglobin, which are more specific and sensitive than total CK or LDH. Together, the presentation and test results make the diagnosis of MI likely in this case.
The cardiac structure includes the heart walls and chambers. Cardiac hypertrophy is an increase in heart size and weight due to mechanical overload. It can be concentric from pressure overload or eccentric from volume overload. Heart failure occurs when the heart cannot pump adequately to meet metabolic demands. It can be due to systolic or diastolic dysfunction. Right heart failure causes venous congestion while left heart failure causes pulmonary congestion.
This document discusses constrictive pericarditis, which occurs when the pericardium thickens and restricts heart function. It can develop acutely from cardiac tamponade, or chronically from conditions like prior cardiac surgery, radiation therapy, or tuberculosis. Symptoms include fluid overload and reduced cardiac output with exertion. Evaluation involves ECG, echocardiogram, CT/MRI, and measuring ventricular filling pressures. Treatment depends on whether the constriction is transient, chronic, or occult. Chronic symptomatic cases require pericardiectomy, while transient cases may resolve with medications over time.
The document discusses the anatomy, functions, pathophysiology, etiologies, clinical features, diagnosis and treatment of pericardial diseases including pericarditis, pericardial effusion, cardiac tamponade, and constrictive pericarditis. Key points include: the pericardium has visceral and parietal layers separated by pericardial fluid; pericarditis can be caused by infection, autoimmune disorders, neoplasms or trauma; tamponade occurs when fluid rapidly accumulates under pressure, compressing the heart; constrictive pericarditis involves fibrosis and scarring that restricts diastolic filling.
The document summarizes mitral valve disorders including mitral stenosis and mitral regurgitation. It covers the anatomy of the mitral valve and describes valvular heart diseases such as stenosis and regurgitation. For mitral stenosis, it discusses etiology as being primarily rheumatic fever, pathophysiology involving decreased mitral valve area and increased left atrial pressure, clinical features such as dyspnea and pulmonary hypertension, physical exam findings including murmurs, and treatment including valve repair/replacement and rate control for atrial fibrillation. For mitral regurgitation, it similarly discusses etiology, pathophysiology, clinical features, exam, workup and treatment involving surgical repair or replacement.
- Constrictive pericarditis results from scarring and loss of elasticity of the pericardial sac, typically due to chronic inflammation and sometimes calcification. This causes the pericardium to thicken and lose its ability to expand and contract normally.
- The inelastic pericardium prevents normal filling of the heart chambers, especially in mid to late diastole. Inspiration does not decrease pressure in the left ventricle as it normally would due to the thickened pericardium isolating the heart.
- Diagnosis involves physical exam findings like elevated JVP, hepatomegaly, and Kussmaul's sign combined with echocardiography findings like sept
The document provides an overview of pericardial disease including pericarditis, pericardial effusion, cardiac tamponade, and constrictive pericarditis. It discusses the structure and function of the pericardium, signs and symptoms, causes, investigations, and treatments for each condition. Acute pericarditis is usually caused by viral infection and presents with chest pain relieved by sitting forward. Pericardial effusion can lead to cardiac tamponade seen by increased jugular venous pressure and pulsus paradoxus. Constrictive pericarditis is a chronic thickening and scarring of the pericardium most often caused by tuberculosis.
This document discusses the anatomy, assessment, and management of tricuspid valve disease. It covers tricuspid stenosis and tricuspid regurgitation. For tricuspid stenosis, the most common causes are rheumatic fever and infective endocarditis. Symptoms include fatigue and swelling. Transthoracic echocardiogram is used to assess the mean gradient and valve morphology. For tricuspid regurgitation, the most common primary causes are rheumatic fever and carcinoid heart disease. Secondary causes are related to right ventricular dilation. Symptoms are similar to stenosis. Echocardiogram can assess the severity of regurgitation and pulmonary pressures. Management involves medical therapy depending on severity of disease.
This document discusses hypertrophic cardiomyopathy (HCM), including its definition, causes, variants, pathophysiology, clinical presentation, diagnostic workup, and management. Key points include:
- HCM is defined by left and/or right ventricular hypertrophy, usually involving the septum with a thickness over 15mm. It is commonly caused by genetic mutations affecting cardiac proteins.
- Presentation can range from being asymptomatic to symptoms of heart failure, angina, or syncope. Exams may reveal murmurs and EKGs often show abnormal patterns. Echocardiograms and cardiac catheterization are used for diagnosis and assessment.
- Management involves medications like beta-blockers to reduce
Mitral stenosis is usually caused by rheumatic fever, which causes fusion and thickening of the mitral valve, restricting its opening. This restricts blood flow from the left atrium to the left ventricle, causing left atrial pressure to rise and lead to pulmonary congestion and breathlessness. The elevated left atrial pressure also raises pulmonary pressures over time, causing pulmonary hypertension, right heart strain, and eventual right heart failure if left untreated. Diagnosis is made through echocardiogram and symptoms include dyspnea, fatigue, chest pain, cough, and palpitations from potential atrial fibrillation. Treatment involves antibiotics to prevent future rheumatic fever, diuretics, and potentially mitral
This document discusses the echocardiographic evaluation of cardiomyopathies. It defines cardiomyopathy and outlines the major classification systems. The main types discussed are dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, restrictive cardiomyopathy, and unclassified cardiomyopathy. Specific features of dilated cardiomyopathy are then reviewed in detail, including morphological features, causes, Doppler findings, and involvement of the right ventricle and left atrium. Evaluation of diastolic dysfunction and ischemic cardiomyopathy are also summarized.
Atrial myxomas are the most common primary cardiac tumors. They typically arise from the interatrial septum and can cause obstruction of blood flow or embolic events. Clinical presentations include signs of congestive heart failure, systemic embolism, and constitutional symptoms. Echocardiography is the primary diagnostic tool and surgical resection is the only effective treatment. While most myxomas are sporadic, around 5% are familial with an inherited pattern and higher recurrence rates after surgery.
Normal Heart
Fist size muscular pump
Pumps 6000 lit of blood daily
Perfuses
tissues with nutrients and
Facilitates
removal of waste products.
Heart diseases
Have severe physiologic consequences
Are leading cause of morbidity and mortality in developed nations
750,000 deaths/ year (In US
Dr Vivek Baliga discusses left atrial myxoma for medical students. Lecture includes a link to MCQs in the video. For access to video, please copy and paste this link --> https://youtu.be/JtkWxbVklgA
This document discusses rheumatic valvular heart disease, focusing on mitral regurgitation, mitral stenosis, and aortic regurgitation.
It begins by outlining the learning objectives and providing an introduction on rheumatic heart disease and how it causes permanent valve damage. The pathophysiology, clinical manifestations, diagnostic modalities, and treatment options are then described for each of the three valvular lesions.
Prevention through secondary prophylaxis with antibiotic administration is emphasized, as 40-60% of patients with acute rheumatic fever can develop rheumatic heart disease without proper prevention. Education is highlighted as critical to ensure patient understanding and adherence to long-term prophylaxis.
Cardiomyopathy refers to diseases of the heart muscle that weaken the heart's ability to pump blood. Dilated cardiomyopathy is characterized by the enlargement and weakening of the heart's main pumping chamber, the left ventricle. The major causes of dilated cardiomyopathy include infections, toxins, inherited conditions, and unknown causes. Symptoms include heart failure and arrhythmias. Diagnosis involves echocardiography and treatments focus on managing symptoms through medications, devices, and transplantation if needed.
This document provides an overview of hypertrophic cardiomyopathy (HCM). It begins with definitions of cardiomyopathy and HCM. It then discusses the historical perspective, genetic basis, morphology, pathophysiology, clinical features, diagnosis, and management of HCM. Some key points include:
- HCM is a genetic heart condition characterized by unexplained thickening of the heart muscle. It is the most common cause of sudden cardiac death in young people.
- The genetic basis involves mutations in genes encoding sarcomere proteins. This leads to impaired relaxation and increased calcium sensitivity of the heart muscle.
- Morphologically, HCM involves asymmetric left ventricular hypertrophy and abnormalities of the mitral valve apparatus. Hist
Infective Endocarditis and It's Surgical ManagementAlireza Kashani
This document defines and describes infective endocarditis. Key points include:
- Infective endocarditis involves infection of the heart valves or structures, most commonly the valves. This can lead to valvular dysfunction, sepsis, or embolism.
- The infection involves bacterial, viral, or fungal invasion of the endocardium and formation of vegetations on the valves or endocardium.
- Risk factors include underlying heart conditions, IV drug use, dental procedures, and indwelling catheters. The aortic and mitral valves are most commonly involved.
- Symptoms may include fever, heart murmur, embolic phenomena, and heart failure. Diagnosis
1) Valvular heart disease is characterized by damage or defects to the heart's valves, with the two most common types being aortic stenosis and mitral regurgitation.
2) The document discusses the different types of valvular heart diseases including their etiology, pathophysiology, clinical manifestations, diagnosis, and treatment. The types covered include mitral stenosis/regurgitation, aortic stenosis/regurgitation, tricuspid stenosis, and pulmonic stenosis.
3) Nursing management of valvular heart disease involves monitoring for symptoms, ensuring proper medical and surgical treatments are followed, and health education about valvular heart conditions.
Valvular heart disease is caused by damage or defects to the heart's valves. The main types are stenosis, where the valve opening is narrowed, and regurgitation, where the valve leaks.
The most common causes are rheumatic fever, which can cause scarring of the valves, and aging/degeneration. Symptoms depend on the severity but can include shortness of breath, chest pain, and fatigue. Treatment options include medications to manage symptoms or surgery to repair or replace the damaged valve.
This document provides an overview of cardiovascular pathology. It discusses various types of heart disease including failure of the heart to pump adequately, obstructions to blood flow, regurgitation of blood back through the valves, shunted or redirected blood flow, disorders of cardiac conduction, and rupture of the heart or major vessels. Specific conditions covered include ischemic heart disease, valvular heart diseases like rheumatic heart disease and infective endocarditis, arrhythmias, myocarditis, and heart failure. The pathogenesis, clinical features, and complications of these conditions are described.
The document provides an overview of cardiovascular pathology, discussing various heart diseases including:
1. Failure of the heart to pump effectively due to weak contractions (systolic dysfunction) or impaired relaxation (diastolic dysfunction).
2. Obstructions, regurgitation, and shunted blood flow due to valve problems or defects, overworking the heart.
3. Electrical conduction disorders causing arrhythmias that prevent effective pumping.
Specific conditions like ischemic heart disease, arrhythmias, valvular diseases, infective endocarditis, myocarditis and their causes and clinical features are then described in more detail.
This document discusses hyperemia and congestion, two vascular events that involve an increased volume of blood in a particular tissue. Hyperemia is an active process of arteriolar dilation that increases blood volume on the arterial side, while congestion is a passive process caused by impaired venous outflow that increases blood volume on the venous side. Both lead to increased hydrostatic pressure and edema. Examples of congestion discussed include nutmeg liver seen in right-sided heart failure and pulmonary edema seen in left-sided heart failure. Microscopic findings of congestion in the liver include centrilobular necrosis and hemorrhage, while the lungs show engorged capillaries, edema, and hemorrhage.
This document discusses various types of valvular heart disease, including their causes, pathophysiology, clinical manifestations, investigations, and management. It covers mitral stenosis, mitral regurgitation, mitral valve prolapse, aortic stenosis, aortic regurgitation, tricuspid stenosis, and tricuspid regurgitation. For each condition, it provides details on etiology, effects on heart function, common symptoms, diagnostic tests, medical and surgical treatment options, and patient education points.
This document discusses various types of valvular heart disease, including causes, pathophysiology, clinical manifestations, investigations, and management. It covers the main heart valves - mitral, aortic, tricuspid and pulmonary valves. The major types of valvular abnormalities discussed are stenosis (narrowing) and regurgitation (leakage). Specific valve diseases covered in detail include rheumatic mitral stenosis, mitral regurgitation, mitral valve prolapse, aortic stenosis, aortic regurgitation, tricuspid stenosis/regurgitation, and pulmonary stenosis/regurgitation. Surgical and medical management strategies are presented for each condition. Prosthetic heart valves, both mechanical and biological,
This document discusses various types of valvular heart disease, including causes, pathophysiology, clinical manifestations, investigations, and management. It covers the main heart valves - mitral, aortic, tricuspid and pulmonary valves. The major types of valvular abnormalities discussed are stenosis (narrowing) and regurgitation (leakage). Specific valve diseases covered in detail include rheumatic mitral stenosis, mitral regurgitation, mitral valve prolapse, aortic stenosis, aortic regurgitation, tricuspid stenosis/regurgitation, and pulmonary stenosis/regurgitation. Surgical and medical management strategies are presented for each condition. Prosthetic heart valves, both mechanical and biological,
A 52-year-old woman presents with gradually worsening shortness of breath over 2 years and now requires 2 pillows at night. On examination, she has an apical diastolic murmur. This suggests she has valvular heart disease, likely mitral stenosis given the murmur location and symptoms. Mitral stenosis narrows the opening between the left atrium and ventricle, causing shortness of breath and difficulty sleeping flat. Surgical options may include balloon valvuloplasty or valve replacement depending on severity.
1. The document provides an overview of cardiovascular pathology, covering topics like ischemic heart diseases, valvular heart diseases, shock, and heart anatomy.
2. Key points include the causes and presentations of myocardial infarction, different types of angina, and degenerative and rheumatic causes of valvular diseases.
3. Infective endocarditis and its complications are discussed, as well as types of pericardial diseases like effusions and acute suppurative pericarditis.
1. The document provides an overview of cardiovascular pathology, covering topics like ischemic heart diseases, valvular heart diseases, shock, and heart anatomy.
2. Key points include the causes and presentations of myocardial infarction, different types of angina, and degenerative and rheumatic causes of valvular diseases.
3. Infective endocarditis and its complications are discussed, as well as types of pericardial diseases like effusions and acute suppurative pericarditis.
Inflammatory disorders of the blood vessels, known as vasculitides, can affect arteries, veins, and capillaries through various immunological mechanisms. Three key types are summarized: (1) Large vessel vasculitis like giant cell arteritis typically involves the temporal artery and causes headaches and vision problems. (2) Medium vessel vasculitis such as polyarteritis nodosa involves arteries in organs like the kidneys and skin. (3) Small vessel vasculitis often presents as palpable purpura on the skin such as in Henoch-Schönlein purpura, a type of vasculitis more common in children.
edema and shock Definition, pathogenesis and morphologySumanPoudel36
This document discusses edema and shock. It defines edema as abnormal accumulation of fluid in the interstitial space and describes different types of edema including transudate and exudate. Shock is defined as a life-threatening condition of cardiovascular collapse characterized by systemic hypotension and hypoperfusion. The main types of shock are hypovolemic, cardiogenic, septic, anaphylactic, and neurogenic. The stages of shock are described as compensated, decompensated, and irreversible based on the progression of tissue hypoxia and organ failure.
Anti diabetic medications
Patients who are intolerant of metformin are unlikely to be successful with a third trial of that agent. Empagliflozin, an SGLT2 inhibitor, is considered a second-line choice for patients who are intolerant of metformin. Both sitagliptin, a DPP-4 inhibitor, and liraglutide, a GLP-1 receptor agonist, should be avoided or used with caution in patients with a history of pancreatitis
-Linagliptin is not cleared by the kidney second choice if GFR<35(Stop Metformin)
only liraglutide has been shown to lower the risk of recurrent cardiovascular events and has received FDA approval for this indication
Empagliflozin, an SGLT2 inhibitor, has also been associated with secondary prevention of cardiovascular disease.
Fasting C-peptide levels are markedly elevated in patients with T2DM, but in people with T1DM, C-peptide levels should be low
. TZDs tend to cause fluid retention and should not be used in patients with congestive heart failure
References
ADA
Step up to medicine
Toronto notes
UpToDate
ABFM
This document discusses tubulointerstitial disorders, which are diseases affecting the renal tubules and interstitium. Tubulointerstitial disorders are distinguished from glomerular diseases by the absence of nephritic or nephrotic syndrome and the presence of tubular dysfunction manifesting as defects in concentration ability, polyuria, nocturia, and metabolic acidosis. Common tubulointerstitial disorders discussed include acute tubular necrosis, tubulointerstitial nephritis, pyelonephritis, drug-induced tubulointerstitial nephritis, analgesic nephropathy, and diseases causing hypercalcemia and nephrocalcinosis.
The key features in this case are:
- Age of 4 years old
- Abdominal mass
- Hematuria
- Hypertension
This combination of findings is classic for Wilms tumor (nephroblastoma), which is the most common renal tumor in children.
The diagnosis is Wilms tumor (D).
Membranous GN
MOST COMMON cause is idiopathic (85%); peak age 30-50; male:female, 2:1
May be secondary to:
Drugs-captopril, penicillamine, gold, mercury, trimethadione, NSAIDS
Infections-malaria (P. malariae), leprosy, schistosomiasis, syphilis, hepatitis B and C, filariasis, hydatid disease and enterococcal endocarditis
Diseases-malignancy (Carcinoma of breast, lung, colon, stomach, and esophagus) melanoma, renal cell CA, SLE, sarcoidosis, diabetes, thyroiditis, sickle cell anemia, Crohn’s disease
1. Women aged 21-24 with ASC-US or LSIL should have repeat cytology in 1 year; if negative twice, return to routine screening, but AGC, HSIL or ASC-H requires colposcopy.
2. Women over 30 should have co-testing every 5 years; if HPV negative the risk is low, but a positive HPV requires repeat co-testing in 1 year or colposcopy if cytology is ASC-US or greater.
3. ASC-H in women over 25 requires colposcopy regardless of HPV results due to possibility of significant abnormality.
The document discusses several disorders of the pleura and lungs, including pleural effusions, pneumothorax, and mesothelioma. Pleural effusions can be transudative or exudative depending on disturbances to Starling forces or increased vessel permeability. Pneumothorax can be spontaneous due to bleb rupture or tension pneumothorax from a flap-like pleural tear. Mesothelioma is a malignant tumor of the pleura associated with asbestos exposure that encases the lung.
Restrictive lung diseases (interstitial lung diseases)
Histological Structure of Alveoli
The wall of the alveoli is formed by a thin sheet of tissue separating two neighbouring alveoli.
This sheet is formed by epithelial cells and intervening connective tissue.
Collagenous , reticular and elastic fibres are present.
Between the connective tissue fibres we find a dense, anastomosing network of pulmonary capillaries. The wall of the capillaries are in direct contact with the epithelial lining of the alveoli.
Neighbouring alveoli may be connected to each other by small alveolar pores (pores of Kohn).
The epithelium of the alveoli is formed by two cell types:
Alveolar type I cells (small alveolar cells or type I pneumocytes) are extremely flattened and form the bulk (95%) of the surface of the alveolar walls.
Alveolar type II cells (large alveolar cells or type II pneumocytes) are irregularly (sometimes cuboidal) shaped.
They form small bulges on the alveolar walls.
Type II alveolar cells contain are large number of granules called cytosomes (or multilamellar bodies), which consist of precursors to pulmonary surfactant (the mixture of phospholipids which keep surface tension in the alveoli low) .
Cilia are absent from the alveolar epithelium and cannot help to remove particulate matter which continuously enters the alveoli with the inspired air. Alveolar macrophages take care of this job. They migrate freely over the alveolar epithelium and ingest particulate matter.
FUNCTIONS OF PULMONARY CELLS
Type I pneumocytes
Permeable to Oxygen and CO2, do not divide
Type II pneumocytes
Reserve cells
secrete pulmonary surfactant
Serve as repair cells
Alveolar macrophages
Phagocytosis
Pores of Kohn (allow passage of Macrophages)
Asthma
A chronic relapsing inflammatory disorder characterized by:
Hyper-reactivity of the respiratory tree to various stimuli leading to
Reversible airway obstruction
Obstruction produced by combination of :
Constriction of bronchial musculature (bronchospasm)
Mucosal inflammation (edema)
Excessive secretion of mucus.
Clinically Manifested by :
Difficulty in breathing (Dyspnea)
Wheeze (a soft whistling sound during expiration)
Difficulty in expiration.
Asthma is:
Episodic and reversible airway disease
Primarily targets the bronchi and terminal bronchioles
MC chronic respiratory disease in children
Two types:
Extrinsic asthma (allergic, atopic)
Intrinsic asthma (non-allergic asthma or idiosyncratic asthma)
Obstructive diseases : Chr.by
Obstruction to airflow out of the lungs
Due to partial or complete obstruction in airway.
Increase in lung compliance and
Decrease in lung elasticity.
Restrictive diseases : Chr by
reduced expansion of lung parenchyma with problems in getting air in the lungs.
Lung compliance is decreased
Elasticity is increased: once air is in the lungs it comes out rapidly on expiration.
Tumors of lung
Malignant tumors of lung
Primary
Metastatic
Metastatic lung cancer
More common* than primary lung cancer.
Breast cancer (MCC)
Renal Cell carcinoma
Choriocarcinomas
Colorectal carcinomas
Appear as: "Cannon Balls” On X rays
This document discusses several types of pneumonia including nosocomial, aspiration, and lung abscess pneumonia. It provides details on causative organisms, pathophysiology, clinical features, diagnosis and treatment. Key points include:
- Nosocomial pneumonia is associated with immunosuppression, antibiotics, and respirators. Common organisms are E. coli, Pseudomonas aeruginosa, and S. aureus.
- Aspiration pneumonia results from gastric content aspiration and is characterized by necrotizing inflammation. Causative organisms include a mixture of oral aerobes and anaerobes like Bacteroides and S. pneumoniae.
- Lung abscesses develop most commonly from aspiration or
1. Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by diffuse alveolar capillary damage and severe pulmonary edema, resulting in hypoxemia that is refractory to oxygen therapy.
2. ARDS is caused by direct or indirect injury to the lungs from sources such as sepsis, gastric aspiration, trauma, or smoke inhalation. This causes damage to the alveolar capillary endothelium and epithelium.
3. The damage leads to increased capillary permeability, leakage of fluid into the alveoli, and formation of hyaline membranes. This results in impaired gas exchange and respiratory failure.
Heavy Metal poisoning
Lead, Arsenic, and Mercury
Produce acute or chronic intoxications
Blood tests are most useful for screening for heavy metal poisoning
Environmental diseases can be caused by chemical, physical, or biological agents. Tobacco use is a major cause of preventable death and disease worldwide. Smoking causes lung cancer, COPD, cardiovascular disease, and many other cancers. Secondhand smoke also increases disease risk. Alcohol abuse commonly causes liver disease, cancers, neurological disorders like Wernicke's encephalosis, and fetal alcohol syndrome. Indoor air pollutants like carbon monoxide from fires or malfunctioning heaters can cause hypoxia and death at high levels. Many therapeutic drugs and recreational drugs can also cause adverse environmental diseases if misused or abused.
This document discusses functional vascular disorders and Raynaud's phenomenon. It describes Raynaud's phenomenon as intermittent attacks of ischemia to the fingers, toes, ears or nose due to spasms of small arteries. Raynaud's phenomenon is classified as either idiopathic/Raynaud's disease which occurs alone in young healthy women, or secondary Raynaud's which occurs with connective tissue diseases. Hypertension is also discussed, including types, pathophysiology involving the kidneys and renin-angiotensin system, complications such as heart and brain damage, and malignant hypertension.
Are localized abnormal dilations of arteries.
Result due to weakening of the vessel wall.
Have the tendency to rupture.
Law of Laplace: states that as the diameter of aneurysm increases the wall stress increases : further enlargement and rupture is inevitable.
Aneurysms are classified by:
Location ( e.g abdominal aortic aneurysm)
Etiology (e.g. syphlitic aneurysm)
Shape (e.g. fusiform , saccular)
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...Jim Jacob Roy
In this presentation , SBP ( spontaneous bacterial peritonitis ) , which is a common complication in patients with cirrhosis and ascites is described in detail.
The reference for this presentation is Sleisenger and Fordtran's Gastrointestinal and Liver Disease Textbook ( 11th edition ).
3. 3
Acute Rheumatic Fever
• Is a multisystem immunologic disorder.
– Follows streptococcal infection
– Characterized by inflammatory reactions
involving:
• Heart, joints, basal ganglia and other
tissues.
• Epidemiology:
– Occurs at 5-15 years of ages
– Develops 1 to 5 weeks after group A beta
hemolytic streptococcal pharyngitis or scarlet
fever
– Possible relapse may occur leading to chronic
rheumatic heart disease.
4. 4
Acute Rheumatic Fever
• Pathogenesis:
– Immune mediated disease that follows group A
streptococcal infection
• Blood cultures are negative
• It is an immunologic reaction and not a
septicemia.
– Antibodies develop against group A
streptococcal M proteins
• Antibodies cross react with similar proteins
in human tissue (molecular mimicry).
5. 5
Acute Rheumatic Fever
Clinical findings and Diagnosis
• Jone’s criteria for ARF:
– Major criteria
1. Migratory asymmetric Polyarthritis
2. Carditis
3. Sydenham’s chorea
4. Subcutaneous nodules
5. Erythema marginatum
– Minor criteria:
• Fever , Arthralgia
• Leukocytosis, elevated ESR ,C-reactive protein
(CRP) and antistreptolysin O (ASO titers).
• Previous rheumatic fever or rheumatic heart
disease
6. 6
Acute Rheumatic Fever
• Migratory asymmetric Polyarthritis:
– MC (~ 75%) initial presentation of ARF
– Occurs in large joints (Knees) and small joints
(wrists)
– No permanent joint damage
10. 10
Acute Rheumatic Fever
2. Myocarditis: MC COD in acute disease*
– Aschoff Body:
• Is the pathognomonic lesion of RF
• Consists of Central area of fibrinoid
necrosis surrounded by
• Aschoff cells (aka Anitschkow cell)
– Are reactive histiocytes
– Fuse and form Aschoff multinucleated
giant cells.
13. 13
Acute Rheumatic fever
• Endocarditis:
– Characterized by inflammation of valve surfaces
– Leading to development of
• Sterile verrucoid appearing vegetations (platelet
and fibrin clots) along the line of closure of the
valve
• Most commonly involves
– Mitral valve ( then aortic valve)
– Vegetations in RF:
• Do not embolize
• Can cause Mitral valve regurgitation or Aortic
valve regurgitation May result in CHF.
15. 15
Acute Rheumatic fever
• Subcutaneous nodules:
– Occur on extensor
surface
– Fibrinoid necrosis
surrounded by
histiocytes
– Histologically same as
that seen in
rheumatoid arthritis
17. 17
Acute Rheumatic fever
• Sydenham’s chorea:
– Reversible rapid, involuntary
movements affecting all muscles
– Late manifestation of ARF
18. 18
Acute Rheumatic fever
• Diagnosis of ARF
– Requires Presence of (Jone’s criteria)
• two major or
• One major and two minor
• Prognosis:
– Mortality very low
– MC COD is heart failure
– Recurrent attacks of ARF can lead to
Chronic rheumatic heart disease*
19. 19
Chronic Rheumatic Heart Disease
• Occurs if
– First attack of ARF is severe or
– With recurrent attacks of ARF
• Chronically damaged valves show:
– Fibrous thickening , fusion of commissures and
calcification, generating fishmouth or
buttonhole deformity.
• Most common valves involved are MV and AV.
– Resulting in mitral and aortic stenosis
22. 22
Complications of Chronic Rheumatic
Heart Disease
• Bacterial endocarditis:
– Damaged valves easily seeded by bacteria
• Mural thrombi:
– Complication of mitral stenosis
– Usually form in the left atrium
– Can give rise to thromboemboli infarcts
• Congestive hear failure:
– Due to Aortic stenosis
25. 25
Mitral Stenosis
• Etiology:
– Most often caused by recurrent attacks of
rheumatic fever
• Pathophysiology:
– Narrowing of the mitral valve orifice
– Volume overload in left atrium and lungs
– Left atrium becomes dilated and hypertrophied
• Due to increased work in filling the ventricle
in diastole
28. 28
Mitral Stenosis: Clinical findings
• Dyspnea and hemoptysis with rust colored
sputum:
– Due to pulmonary capillary congestion and
hemorrhages into the alveoli (heart failure
cells).
• Pulmonary hypertension:
– Due to chronic backup of atrial blood into the
pulmonary vein.
– RVH eventually develops
• Atrial fibrillation:
– Due to left atrial dilation and hypertrophy
– Intra atrial thrombus develops due to stasis.
• Can embolize
29. 29
Mitral Stenosis: Clinical findings
• Dysphagia for solids:
– Left atrium is the most posteriorly located
chamber in the heart
– Dilation of the left atrium compresses the
esophagus.
• Opening snap
– Occurs when non-pliable valve gives way under
increased left atrial pressure
• OS followed by mid diastolic rumble:
– Best heard at apex ,increases with expiration.
31. 31
Mitral Regurgitation
• Causes:
1. Mitral valve prolapse is the MC cause
2. Left sided heart failure stretching of MV
ring
3. Infective endocarditis
4. Rupture of papillary muscle
• Usually right coronary artery thrombosis
32. 32
Mitral Regurgitation
• Pathophysiology:
– Reflux of blood into LA during systole
• Due to an incompetent mitral valve or
dilated mitral valve ring
– Volume overload in LV and LA
• Leads to dilatation and hypertrophy of both
chambers
• Results in LHF
33. 33
Mitral Regurgitation
• Clinical findings:
– Pansystolic murmur with radiation into the
axilla
• Heard best at apex
• Increases on expiration
– S3 heart sound: volume overload in LV
– Dyspnea and cough from LHF
35. 35
Mitral Valve Prolapse (MVP)
• Mitral valve leaflets are enlarged and floppy
– Prolapse in left atrium during systole
• Epidemiology:
– MC indication for valve replacement
– MC valvular disease in the young population
– More common in women
– Associated with Marfan and Ehlers Danlos
syndrome
36. 36
Mitral Valve Prolapse (MVP)
• Pathophysiology:
– Leaflets prolapse into the LA during systole
like a parachute
• Anterior and posterior leaflets***
• Pathology:
– Valve leaflets are deformed and redundant
– Valves become redundant (voluminous): due to:
• Myxomatous degeneration** of leaflets
– Due to excess production of dermatan
sulfate.
37. 37
Mitral Valve Prolapse (MVP)
Clinical findings:***
• Most patients are asymptomatic
• Heart murmur:
– Mid systolic click:
• Occurs when the valve prolapses into LA and
is suddenly restrained by the chordae
tendineae.
– Click followed by a mid to late systolic
regurgitation murmur***
39. 39
Calcific aortic stenosis
of a
congenitally bicuspid aortic valve
Calcific aortic stenosis
in a
three-cuspid aortic valve
40. 40
Aortic Stenosis
• Pathophysiology:
1. Obstruction to left ventricular outflow during
systole
• Decreased SV/CO
2. Reduction in aortic valve orifice area
produces pressure overload in the LV leading
to
• Concentric LV hypertrophy
41. 41
Aortic Stenosis: Clinical findings
1. Systolic ejection murmur*
2. Angina with exercise:
• Decreased blood flow through the stenotic
valves leads to less filling of the coronary
arteries during diastole
• Subendocardium of hypertrophied heart
receives less blood.
3. Syncope with exercise:
• Due to decreased blood flow through brain
4. Hemolytic anemia with schistiocytes
44. 44
Aortic Regurgitation
• Pathophysiology:
1. Retrograde blood flow into the LV
• Due to incompetent valve or dilated valve
ring
– Volume overload of the left ventricle
» Increases stroke volume
45. 45
Aortic Regurgitation
• Clinical findings:
– Early diastolic murmur
– Bounding pulse (water hammer pulse), head
nodding, pulsating uvula.
– Austin flint murmur:
• Due to regurgitant stream hitting the
anterior mitral valve leaflet
• Presence of this murmur is a indication for
replacement of valve.
46. 46
Tricuspid regurgitation
• Etiology:
1. Right sided heart failure
2. Infective endocarditis in IVDA
3. Carcinoid heart disease.
• Pathophysiology:
– Retrograde flow into the RA during systole
– Produces volume overload in RA
– Volume overload in RV.
– Can cause RHF
47. 47
Tricuspid regurgitation
• Clinical findings:
– Pansystolic murmur that increase in intensity
with inspiration
– Pulsating liver
• Blood regurgitates into venous system with
systole
48. 48
Carcinoid heart disease
• Due to metastasis of a carcinoid tumor from
intestine to liver.
• Carcinoid tumors liberate serotonin.
• Carcinoid syndrome is a triad of:
– Cutaneous flushing
– Diarrhea
– Valvular disease
• Serotonin is fibrogenic and causes:
– Fibrosis of tricuspid valve and pulmonary
valves
• Results in tricuspid valve regurgitation and
pulmonary valve stenosis (TIPS).